Virtual Pharmacist

Virtual Pharmacist interprets microarray SNP genotyping data, FASTQ files, and Variant Call Format (VCF) files to provide personalized pharmacogenomic analyses that predict how individual genetic variants influence drug efficacy, dosage, and toxicity.

Key Features:

• Data Input Flexibility: Accepts microarray SNP genotyping data, FASTQ files, and VCF files from diverse sequencing technologies for variant-centered analysis.
• Personalized Drug Response Reporting: Generates reports that annotate the potential impact of individual variants on drug efficacy, dosage requirements, and toxicity risks.
• Pharmacogenomic Biomarker Integration: Annotates and summarizes variants using the US Food and Drug Administration's pharmacogenomic biomarker-labeled drug list and PharmGKB.
• Visualization Tools: Constructs gene-drug-target network visualizations to represent interactions between genetic variants and pharmaceuticals.
• Batch Submission for Group Analysis: Supports batch submissions to perform multivariate analyses and data mining across cohorts to assess variant distributions and drug-response patterns.
• Population-Specific Insights: Performs analyses on population-scale data, including analyses using genomes from the 1000 Genome Project, to highlight differential drug responses among human populations.

Scientific Applications:

• Clinical pharmacogenomics: Informs individualized drug selection and dosing decisions by linking patient variants to drug response annotations.
• Population pharmacogenomic studies: Enables comparative analyses of variant frequencies and predicted drug responses across populations such as those represented in the 1000 Genome Project.
• Variant annotation and biomarker research: Facilitates interpretation of pharmacogenomic biomarkers through integration with FDA and PharmGKB resources.
• Cohort-level data mining: Supports group-level analyses to identify multivariate associations between genetic variation and predicted drug response patterns.

Methodology:

Accepts microarray SNP genotyping data, FASTQ, and VCF inputs; annotates variants using the US Food and Drug Administration's pharmacogenomic biomarker-labeled drug list and PharmGKB; constructs gene-drug-target network visualizations; and supports batch submissions and analyses including comparisons using genomes from the 1000 Genome Project.